02/05/2025
A recent study has uncovered that a protein called NF-kB c-Rel can worsen the symptoms of psoriasis when triggered by the body’s immune system. Psoriasis is a painful skin condition where the immune system causes skin cells to multiply too quickly, forming red, scaly patches. Normally, the immune system helps protect the body, but in psoriasis, it goes overboard and attacks the skin.
Researchers from Case Western Reserve University focused on how c-Rel, a protein, interacts with a specific type of immune cell called dendritic cells. They found that c-Rel becomes active when it receives signals from something called Toll Like Receptor 7 (TLR7), which helps control the body's immune responses. This activation of c-Rel and TLR7 makes the inflammation in the skin worse, triggering more symptoms of psoriasis.
The study also showed that when mice were missing c-Rel, their skin didn’t get as inflamed, and they didn’t develop the usual psoriasis symptoms. This finding suggests that blocking c-Rel could help reduce skin inflammation. In fact, researchers believe that focusing on c-Rel and TLR7 might lead to treatments that specifically target the cause of psoriasis, giving relief to people dealing with this painful condition.
Additionally, the study showed that viruses like HIV, HPV, and hepatitis C, which also activate TLR7, might contribute to the worsening of psoriasis. This means that c-Rel and TLR7 could be involved in other health problems as well, such as lupus or even slow healing in people with diabetes. This research opens the door to new ways of understanding and treating psoriasis and other related diseases.
